Latest News

The hospital’s expanded referral network encompasses Nyeri, Murang’a, Embu, Karatina, Isiolo, Marsabit, Meru, Tharaka-Nithi, Samburu, Nanyuki, and Kirinyaga counties.

This new 35,000 square foot, purpose-built site represents Novartis’s fourth dedicated RLT facility.

The residency program prepares nurses for advanced clinical practice in Adult Critical Care through a curriculum that aligns with national regulatory requirements and international best practices.

Nimbus will leverage its specialized expertise in computational chemistry and structure-based drug design to discover a small molecule drug candidate.

Terumo plans to distribute the product to hospitals, clinics, and emergency care settings nationwide, making the technology widely accessible to medical professionals who perform injections daily.

Inpefa is the first dual SGLT1 and SGLT2 inhibitor approved specifically for heart failure treatment.

The newly acquired state-of-the-art technology empowers surgeons to examine and treat internal organs through a minimally invasive approach that transforms traditional surgical procedures.

The government has fully funded the first phase of the vaccine manufacturing facility, which has already reached completion.

The Advisory Board will play a central role in steering the strategic direction of the Pura Longevity Clinic, PureHealth’s pioneering center focused on personalized health longevity and precision medicine.

The program will also work to increase access to chemotherapy and provide essential emotional support services for patients navigating their cancer journey.